Title: Foreign Intrusion: Unraveling a Deadly and Rare Cause of HaemobiliaThe author encloses herewith a manuscript entitled Foreign Intrusion: Unraveling a Deadly and Rare Cause of Haemobilia . “for publication in a prestigious journal ”Clinical Case Reports Wiley Online. The Corresponding author of this manuscript is Satheesh Munusamy, Bsc, Respiratory therapist and the authors’ contribution as mentioned below with their responsibility in the research.

Title: Unfolding a potential trigger of liver injury in Psoriasis based on literature review and management approach, a case reportThe author encloses herewith a manuscript entitled “Unfolding a potential trigger of liver injury in Psoriasis based on literature review and management approach, a case report “for publication in a prestigious journal ”Clinical Case Reports Wiley Online. The Corresponding author of this manuscript is Saba Nabavi Monfared, PHARMD and the authors’ contribution as mentioned below with their responsibility in the research.

COVID 19 has created one of the world’s worst pandemics and is associated with various life-threatening complications, such as Cytomegalovirus (CMV) co-infection. We present a life-threatening CMV viremia co-infection in a none-immunocompromised COVID 19 patient to highlight our management approach and a comprehensive literature review.

Chronic myeloid leukemia (CML) is a myeloproliferative disorder due to translocation between chromosomes (9, 22), known as the “Philadelphia chromosome.” In 2016, the World health organization (WHO) introduced a new clinical entity of de novo acute myeloid leukemia (AML). Both diseases share some commonalities, therefore, create a challenge to diagnose.

DiGeorge syndrome, an immunodeficiency disorder due to long arm microdeletion of chromosome 22. Isolated hemolysis is rarely seen in DiGeorge syndrome and is usually reported in conjunction with idiopathic thrombocytopenic purpura. We report a case of DiGeorge syndrome with AIHA, which was successfully managed by intravenous steroids and intravenous immunoglobulins.

Pulmonary Tuberculosis (PTB) and Novel Coronavirus disease 2019 (COVID 19) primarily affect the lungs. Both diseases present with fever, cough, and shortness of breath and possess thrombotic potential as well. Therefore in COVID 19 pandemic, PTB must be taken into consideration for suspected cases in order to avoid fatal consequences.